DVAX - Dynavax Technologies Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Total Revenue 8,198 327 11,043 4,050
Cost of Revenue 85,885 64,988 84,493 86,943
Gross Profit -77,687 -64,661 -73,450 -82,893
Operating Expenses
Research Development - - - -
Selling General and Administrative 64,770 27,367 37,257 22,180
Non Recurring - - - -
Others - - - -
Total Operating Expenses 161,517 93,549 121,750 109,123
Operating Income or Loss -153,319 -93,222 -110,707 -105,073
Income from Continuing Operations
Total Other Income/Expenses Net -5,580 -1,932 -1,737 -1,721
Earnings Before Interest and Taxes -153,319 -93,222 -110,707 -105,073
Interest Expense -9,338 -9,338 -9,338 -572
Income Before Tax -158,899 -95,154 -112,444 -106,794
Income Tax Expense - - - -
Minority Interest - - - -
Net Income From Continuing Ops -158,899 -95,154 -112,444 -106,794
Non-recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect Of Accounting Changes - - - -
Other Items - - - -
Net Income
Net Income -158,899 -95,154 -112,444 -106,794
Preferred Stock And Other Adjustments - - - -
Net Income Applicable To Common Shares -158,899 -95,154 -112,444 -106,794